Skip to content

Clinical trials

Completed Phase 1 Parkinson Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 1 Status: Completed Clear all

251 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20034
20043
20058
20068
20074
20086
200917
20109
201113
201212
201311
201422
201511
201610
201716
201819
201919
202012
20218
202213
202312
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed251

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bial - Portela C S.A.44
Luye Pharma Group Ltd.10
Institute for Neurodegenerative Disorders7
H. Lundbeck A/S6
NeuroDerm Ltd.6
Kyowa Kirin Co., Ltd.5
Pfizer5
AbbVie4
Affiris AG4
Merck Sharp & Dohme LLC4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease251
Alzheimer Disease10
Multiple System Atrophy8
Movement Disorders7
Neurodegenerative Diseases7
Parkinsonian Disorders7
Dyskinesias5
Tauopathies5
Central Nervous System Diseases3
Deglutition Disorders3

Trials

Showing 1 to 25 of 251. Each trial links to its page on Pharma Observatory.

151 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.